Nature communications
Epigenome-wide analysis identifies DNA methylation mediators of treatment-related cardiometabolic risk in survivors of childhood cancer.
Tiffany Eulalio, Yoonji Kim, Xiaoxi Meng, Noel-Marie Plonski, Kyla Shelton, Heather Mulder, Emily Plyler, John Easton, Xiang Chen, Jinghui Zhang, Emily Walker, Geoffrey Neale, Min Ni, John T Lucas, Nilanjan Chatterjee
Published: 202610.1038/s41467-026-68689-6
Abstract
Childhood cancer survivors face increased cardiometabolic risks from cancer treatment exposures, yet mechanisms remain unclear. Here, epigenome-wide analysis identifies 1893 DNA methylation (DNAm) sites in peripheral-blood-mononuclear-cells (PBMCs) a…
Preview only. Read the full abstract at the source